v3.25.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (6,848,483) $ (7,717,794)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 74,182 75,618
Stock-based compensation expense 6 20,094
Amortization of right-of-use asset 96,499 123,479
Non-cash interest expense for note payable 307,563
Write-off and impairment of property and equipment 42,937 3,411
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 333,881 150,325
Deferred offering costs 265,081
Other non-current assets 27,352 (6,594)
Accounts payable 69,133 (346,352)
Accrued expenses and other current and non-current liabilities 150,918 (695,653)
Net cash used in operating activities (6,053,575) (7,820,822)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (173,735) (306,783)
Net cash used in investing activities (173,735) (306,783)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock, gross 8,346,692 12,069,075
Payment for issuance costs of common stock (1,252,425) (1,844,450)
Proceeds from issuance of notes payable 2,000,000
Repayment of notes payable (2,000,000)
Proceeds from exercise of Class D warrants 558
Fractional shares adjustment for reverse stock split (395)
Payment of finance lease (4,027) (3,754)
Net cash provided by financing activities 7,090,240 10,221,034
Net increase in cash and cash equivalents 862,930 2,093,429
Cash and cash equivalents, beginning of period 4,301,945 2,208,516
Cash and cash equivalents, end of period 5,164,875 4,301,945
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION AND NON-CASH INVESTING ACTIVITIES    
Fair value of common stock issued in connection with notes payable $ 307,563